Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cipla
Harvard Business School
Deloitte
US Army
AstraZeneca
Colorcon
Covington
Express Scripts

Generated: April 20, 2018

DrugPatentWatch Database Preview

ZANOSAR Drug Profile

« Back to Dashboard

Which patents cover Zanosar, and when can generic versions of Zanosar launch?

Zanosar is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in ZANOSAR is streptozocin. One supplier is listed for this compound. Additional details are available on the streptozocin profile page.
Drug patent expirations by year for ZANOSAR
Pharmacology for ZANOSAR
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for ZANOSAR
Synonyms for ZANOSAR
1-Methyl-1-nitroso-3-((2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-3-yl)urea
1-methyl-1-nitroso-3-((2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)urea
1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]urea
18883-66-4
2-?DEOXY-?2-?[[(METHYLNITROSOAMINO)CARBONYL]AMINO]-?D-?GLUCOSE
2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose
2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose
2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose
2-Deoxy-2[[(methylnitrosoamino)-carbonyl]amino]-D-glucopyranose
2-Desoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose
24975-EP2275420A1
24975-EP2277858A1
24975-EP2292227A2
24975-EP2295053A1
24975-EP2298767A1
24975-EP2314574A1
27771-EP2272827A1
27771-EP2295055A2
27771-EP2295416A2
27771-EP2295426A1
27771-EP2295427A1
27771-EP2298748A2
27771-EP2298764A1
27771-EP2298765A1
27771-EP2298778A1
27771-EP2305642A2
27771-EP2308833A2
27771-EP2308861A1
27771-EP2311453A1
27771-EP2311842A2
27771-EP2314587A1
27773-EP2277858A1
27773-EP2292227A2
27773-EP2298767A1
27773-EP2314587A1
3-methyl-3-nitroso-1-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
66395-18-4
883S664
8H27GUR065
AB00052092_04
AB00052092_05
AB00052092-03
AB00513906
AB2000735
AC1L1H7V
ACT03364
AKOS025310730
alkylating agent
alpha-D-Glucopyranose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)-
alpha-Streptozocin
Ambap18883-66-4
API0015373
BCBcMAP01_000142
binds to DNA
BIS4356
BPBio1_000754
BSPBio_000684
BSPBio_002734
C-16594
C07313
CA004775
CA011478
CAS-18883-66-4
CC-34553
CCG-39870
CHEBI:9288
CHEMBL1603
D-Glucose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)-(9CI)
D05932
D0I8RR
DB00428
DivK1c_000531
DR000799
DSSTox_CID_1282
DSSTox_GSID_21282
DSSTox_RID_76055
DTXSID2021282
Epitope ID:134282
Estreptozocina
HMS1921A07
HMS2092I09
HMS2097C06
HMS501K13
IDI1_000531
KBio1_000531
KBio2_001440
KBio2_004008
KBio2_006576
KBio3_001954
KBioGR_001768
KBioSS_001440
MFCD00006607
MLS004774123
MolPort-003-665-493
N-(Methylnitrosocarbamoyl)-|A-D-glucosamine; Streptozotocin
N-(Methylnitrosocarbamoyl)-alpha-D-glucosamine
N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff
N-D-Glucosyl-(2)-N'-nitrosomethylurea
NCGC00016738-01
NCGC00178500-01
NCGC00178500-02
NCGC00178500-03
NCGC00178500-04
NCGC00178500-07
NCGC00256594-01
NCGC00259408-01
NINDS_000531
NSC-757321
NSC757321
Pharmakon1600-01500543
Prestwick3_000732
s1312
SBI-0051517.P003
SCHEMBL4748
SMP1_000282
SMR001233317
SPBio_000243
Spectrum_000960
SPECTRUM1500543
Spectrum2_000062
Spectrum3_001087
Spectrum4_001244
Spectrum5_001047
SR-01000939745
SR-01000939745-3
streptozocin
Streptozocin (JAN/USAN/INN)
Streptozocin (USAN/INN)
Streptozocin, >=75% alpha-anomer basis, >=98% (HPLC), powder
Streptozocin, >=98.0% (HPLC)
Streptozocin, Vetec(TM) reagent grade, 98%, powder
Streptozocin, Zanosar, STZ,Streptozotocin
Streptozocine
Streptozocinium
Streptozocinum
streptozosin
Streptozoticin
STREPTOZOTOCIN
Streptozotocin - Zanosar
streptozotocin (stz)
STZ
Tox21_110585
Tox21_110585_1
Tox21_201859
Tox21_302974
UNII-8H27GUR065
W-201687
Zanosar (TN)
ZINC3977737
ZX-AFC000345

US Patents and Regulatory Information for ZANOSAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa ZANOSAR streptozocin INJECTABLE;INJECTION 050577-001 May 7, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Farmers Insurance
Julphar
Express Scripts
Boehringer Ingelheim
Chinese Patent Office
Fuji
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.